Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT01708408

The MURDOCK Study Registry and Biorepository Horizon 1.5

The MURDOCK Study Community Registry and Biorepository (Horizon 1.5) aims to create a large-scale community registry and biorepository that can be used as a vehicle for future health services, epidemiologic, clinical trials and other omics-related research.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Duke Clinical Translational Science Institute-MURDOCK Study

Kannapolis, North Carolina, 28081, United States

About this study

The MURDOCK Study Community Registry and Biorepository's activities include enrolling approximately 50,000 participants who live in Cabarrus County and/or Kannapolis, North Carolina. Participants must consent to (1) use of the data provided by the participant through completion of the Participant Registry Questionnaire for epidemiologic population characterization, (2) annual contact to update their MURDOCK Horizon 1.5 database record, (3) release of their medical information, including but not limited to demographic information, problem lists, medications, social and family history, and results of laboratory and other testing modalities from pre-existing paper or electronic health records or electronic health records that may become available in the future, (4) provision of a blood and urine sample, and (5) contact up to four times/year to request participation in additional research studies.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • A resident of Cabarrus County and/or the city of Kannapolis (and surrounding regions) for 6 or more months of the year
  • At least 18 years of age
  • Able to understand and give written informed consent, or have a legal guardian or caregiver present to give informed consent by proxy (assent from a participant between ages 12-18 will be obtained when their parent or legal guardian consents on their behalf).
  • Willing and able to participate in all 5 components of the registry and biorepository as described above in Section III

Exclusion criteria

  • There are no exclusions to participation if all inclusion criteria have been met.

Treatment and study plan

Biomarker studies

Genetic

Primary outcomes

  1. The MURDOCK Study Registry and Biorepository Horizon 1.5

    Time frame: Upto 119 months

    To provide information for large-scale epidemiologic and clinical translational research and the research infrastructure to identify specific phenotypes and outcomes to improve medicine

Sponsors and collaborators

Lead sponsor

Duke University

Other

Registry information

Official study title

Measurement to Understand Reclassification of Disease of Cabarrus/Kannapolis The MURDOCK Study Registry and Biorepository Horizon 1.5

Acronym: MURDOCK

Important dates

Study start
2009
Primary completion
2026
Study completion
2026
First posted
Oct 17, 2012
Registry last updated
Feb 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.